Sleep Aids (Pharmacies) - Benelux

Revenue in the Sleep Aids market is projected to reach US$51.73m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.72%, resulting in a market volume of US$56.35m by 2029.
In global comparison, most revenue will be generated United States (US$1.47bn in 2024).
In relation to total population figures, per person revenues of US$1.72 are generated in 2024.

Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. This market exclusively covers product sales through pharmacies.

Additional information:
The Sleep Aids market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Single Active Ingredient Formulations
Combination Active Ingredient Formulations
Herbal Remedies
Melatonin Products

Prescription Sleep Medications
Products for Chronic Insomnia which are not designed to address only occasional sleep challenges

The Sleep Aids (Pharmacies) market in Benelux has been experiencing significant growth in recent years. Customer preferences for sleep aids have been shifting towards natural and herbal remedies, as well as non-medicated solutions such as sleep hygiene practices and relaxation techniques. This trend is driven by a growing awareness of the potential side effects and dependency issues associated with traditional sleep medications. In addition to the preference for natural and non-medicated sleep aids, there is also an increasing demand for personalized solutions. Customers are seeking products that are tailored to their specific sleep issues, such as insomnia or sleep apnea. This has led to the development of a wide range of sleep aids that target specific sleep disorders and provide customized solutions. Furthermore, the Sleep Aids (Pharmacies) market in Benelux is also benefiting from the overall growth of the wellness industry. As people become more health-conscious and prioritize self-care, the demand for products that promote better sleep and overall well-being has increased. This trend is expected to continue driving the growth of the sleep aids market in the region. Local special circumstances in Benelux also contribute to the development of the Sleep Aids (Pharmacies) market. The region has a high prevalence of sleep disorders, with a significant portion of the population experiencing issues such as insomnia and sleep apnea. This creates a large potential customer base for sleep aids, as people seek solutions to improve their sleep quality. Additionally, the healthcare system in Benelux is well-developed and provides easy access to sleep aids through pharmacies. This accessibility, coupled with the growing awareness of sleep disorders, has contributed to the increasing demand for sleep aids in the region. Underlying macroeconomic factors, such as the aging population and increasing stress levels, also play a role in the development of the Sleep Aids (Pharmacies) market in Benelux. As the population ages, the prevalence of sleep disorders tends to increase, leading to a higher demand for sleep aids. Similarly, the fast-paced and stressful nature of modern life has resulted in more people experiencing sleep problems, further driving the need for sleep aids. Overall, the Sleep Aids (Pharmacies) market in Benelux is experiencing growth due to customer preferences for natural and personalized solutions, the overall growth of the wellness industry, local special circumstances such as a high prevalence of sleep disorders and easy access to sleep aids, and underlying macroeconomic factors such as an aging population and increasing stress levels.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.